GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Market Cap

Genix Pharmaceuticals (TSXV:GENX) Market Cap : C$2.37 Mil (As of Mar. 30, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genix Pharmaceuticals's share price for the quarter that ended in Oct. 2024 was C$0.05. Genix Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Oct. 2024 was 59.22 Mil. Therefore, Genix Pharmaceuticals's market cap for the quarter that ended in Oct. 2024 was C$2.96 Mil.

Genix Pharmaceuticals's quarterly market cap increased from Apr. 2024 (C$2.96 Mil) to Jul. 2024 (C$5.33 Mil) but then declined from Jul. 2024 (C$5.33 Mil) to Oct. 2024 (C$2.96 Mil).

Genix Pharmaceuticals's annual market cap declined from Oct. 2022 (C$3.85 Mil) to Oct. 2023 (C$2.37 Mil) but then increased from Oct. 2023 (C$2.37 Mil) to Oct. 2024 (C$2.96 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genix Pharmaceuticals's Enterprise Value for Today is C$3.17 Mil.


Genix Pharmaceuticals Market Cap Historical Data

The historical data trend for Genix Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Market Cap Chart

Genix Pharmaceuticals Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.77 8.88 3.85 2.37 2.96

Genix Pharmaceuticals Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.37 2.37 2.96 5.33 2.96

Competitive Comparison of Genix Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Market Cap falls into.


;
;

Genix Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Genix Pharmaceuticals's Market Cap for the fiscal year that ended in Oct. 2024 is calculated as

Market Cap (A: Oct. 2024 )=Share Price (A: Oct. 2024 )*Shares Outstanding (EOP) (A: Oct. 2024 )
=C$0.05*59.224
=C$2.96

Genix Pharmaceuticals's Market Cap for the quarter that ended in Oct. 2024 is calculated as

Market Cap (Q: Oct. 2024 )=Share Price (Q: Oct. 2024 )*Shares Outstanding (EOP) (Q: Oct. 2024 )
=C$0.05*59.224
=C$2.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genix Pharmaceuticals  (TSXV:GENX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Genix Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Genix Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically, the company operates only in Canada.
Executives
Sina Pirooz Director
Paul Chow 10% Security Holder, Director
Jamie A. Lewin Director

Genix Pharmaceuticals Headlines

No Headlines